Makati has a training culture that nobody outside it quite believes. The CBD runs on a schedule where the gym happens at six in the morning or eight at night, wedged either side of a corporate day, by people in their thirties and forties who have been lifting or running or playing something competitive for a decade and are no longer getting away with it. That combination produces a very specific complaint: an overuse injury in a rotator cuff, an Achilles, a patellar tendon or an elbow, which has been managed rather than resolved, sometimes for a year.
That is the reader who arrives at BPC-157, and it is worth being clear about what the evidence actually is before the logistics. BPC-157 has been studied in animal models for tendon and ligament work, with rat Achilles detachment and tendon outgrowth among the most cited experiments, and the mechanisms usually described are angiogenesis and the nitric oxide pathway. The literature is preclinical. It is not a treatment for a human injury, nothing about it is approved for human therapeutic use in this country, and I am not going to pretend the Makati version of that reader is doing anything other than self-directed research on themselves.
What separates the Makati buyer from the rest of the metro is impatience with process rather than price. Nobody in Salcedo is comparing five suppliers on a spreadsheet. They want a decision made in six minutes and a delivery that does not require them to be anywhere at a specific time, which is exactly the thing that goes wrong here.